These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7791657)
41. KR 339 in the treatment of Parkinsonian tremor. Iivanainen M Acta Neurol Scand; 1974; 50(4):469-77. PubMed ID: 4604665 [No Abstract] [Full Text] [Related]
42. The effect of 2:2-diphenyl-4-N-hexamethylenimino-butyramide methiodide on experimental chronic ulcer in glandular stomach of rats. Hisamatsu T; Nakazawa T; Koeda T Jpn J Pharmacol; 1971 Apr; 21(2):139-54. PubMed ID: 5314275 [No Abstract] [Full Text] [Related]
43. Endophthalmitis associated with Haemophilus influenzae type b bacteremia and meningitis. Sastry RV; Baker CJ Am J Dis Child; 1979 Jun; 133(6):606-8. PubMed ID: 312601 [TBL] [Abstract][Full Text] [Related]
44. [Intraocular pressure after cataract extraction with implantation of intraocular lenses]. KaĆuzny J; Debowska-Weiss J; Olejarz E Klin Oczna; 1990 Nov; 92(9-10):173-4. PubMed ID: 2102953 [TBL] [Abstract][Full Text] [Related]
45. [Tremaril--a new antiparkinsonian drug]. Naess K Tidsskr Nor Laegeforen; 1969 Aug; 89(16):1276-7. PubMed ID: 5375358 [No Abstract] [Full Text] [Related]
46. Poisoning with homatropine. Blackburn WD; Spyker DA Va Med; 1979 Sep; 106(9):689-91. PubMed ID: 582643 [No Abstract] [Full Text] [Related]
47. Experiences with cogentin in the treatment of Parkinsonism. A one-year controlled study of 94 patients. Strang RR Acta Neurol Scand; 1966; 41(4):413-8. PubMed ID: 4393610 [No Abstract] [Full Text] [Related]
48. Pharmacologic pupillary modulation in the perioperative period. Alfonso E; Abelson MB; Smith LM J Cataract Refract Surg; 1988 Jan; 14(1):78-80. PubMed ID: 3339553 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of a new preoperative ophthalmic solution. Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531 [TBL] [Abstract][Full Text] [Related]
50. Stability of extemporaneously prepared ophthalmic solutions for mydriasis. Camp NA; Nadra JT; Hughes SE; Gilbert JM; Zhao F Am J Health Syst Pharm; 2018 May; 75(9):e231-e235. PubMed ID: 29691266 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of various vasoconstrictors in cataract surgery. Mathur JS; Mehra KS; Thakur V; Nema HV Acta Ophthalmol (Copenh); 1969; 47(2):411-4. PubMed ID: 5820157 [No Abstract] [Full Text] [Related]
52. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants. Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737 [TBL] [Abstract][Full Text] [Related]
53. [Tremor. Possibilities and limits of drug therapy]. Diener HC Med Monatsschr Pharm; 1990 Jan; 13(1):11-3. PubMed ID: 2304413 [No Abstract] [Full Text] [Related]
55. Effect of postoperative mydriatics on the iris. Ahmed S; Mann P; Gaskell A; Roxburgh S J Cataract Refract Surg; 1996 Jun; 22(5):597-600. PubMed ID: 8784633 [TBL] [Abstract][Full Text] [Related]
56. Pupillary dilatation with single eyedrop mydriatic combinations. Apt L; Henrick A Am J Ophthalmol; 1980 Apr; 89(4):553-9. PubMed ID: 7369319 [TBL] [Abstract][Full Text] [Related]
58. [A new method for the combined use of short acting cyclopegic drugs]. Miranda MN Bol Asoc Med P R; 1976 Jan; 68(1):1-4. PubMed ID: 1062204 [No Abstract] [Full Text] [Related]